BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
Metrics
Affected Vendors & Products
Advisories
| Source | ID | Title |
|---|---|---|
EUVD |
EUVD-2017-8835 | BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility. |
Fixes
Solution
No solution given by the vendor.
Workaround
No workaround given by the vendor.
References
History
No history.
Status: PUBLISHED
Assigner: mitre
Published:
Updated: 2024-08-05T20:59:17.571Z
Reserved: 2017-12-13T00:00:00
Link: CVE-2017-17678
No data.
Status : Modified
Published: 2021-05-19T14:15:07.367
Modified: 2024-11-21T03:18:26.867
Link: CVE-2017-17678
No data.
OpenCVE Enrichment
No data.
EUVD